Latest Report Available at Orbis
research Opthalmic Drugs Market provides pin-point analysis for changing
competitive dynamics and a forward looking perspective on different factors
driving or restraining industry growth.
Ophthalmic
drugs and device market is expected to grow at an exponential rate in the coming
years due to the impact in prevalence of eye disease and an increased growth in
the percentage of the cataract population. The above developments have resulted
in an increase in the production of new ophthalmic devices which in turn has
caught the attention of the people. People are increasingly willing to opt for
ophthalmic surgeries so that their eye disorders get treated effectively.
Request sample copy of this
report at Global
Opthalmic Drugs Market Growth, Trends and Forecasts (2017 - 2022)
The Global Ophthalmology Drugs and Devices
Market is expected to become a $40 billion market by 2015 and is expected to
grow at a CAGR of 6.1% from 2010-2015. The global ophthalmic drugs market was
valued as a $17.3 billion industry in 2013. This industry is expected to grow
at a CAGR of 5.4% and is set to become a $22.5 billion industry by 2018.
The
Global markets for Ophthalmic drugs and devices are basically segmented into
three categories. The segmentations are done on the basis of different drugs
used in the treatment of eye disorders. These included drugs for Glaucoma,
infections and inflammations.
The major drivers for this market are the availability of new drugs and devices, huge demographic shift towards the emerging markets and the increase in the cataract population. The major constraints being expensive procedures, economic slowdown in developed markets.
The major drivers for this market are the availability of new drugs and devices, huge demographic shift towards the emerging markets and the increase in the cataract population. The major constraints being expensive procedures, economic slowdown in developed markets.
The market is again divided on the basis of geography. In the global market US has the largest market share. In the European sector UK has the major share. Recent developments and analysis show that the emerging markets are rapidly rising due to the increase in the cataract population and are expected to show stiff competition against the major players like USA and UK.
The major companies with a share in this market are Abbott Laboratories, Novartis, Pfizer, Bausch & Lomb, Johnson & Johnson, Merck & Co, Inc., Roche Diagnostics,etc.
Browse Complete Report @ http://www.orbisresearch.com/reports/index/global-opthalmic-drugs-market-growth-trends-and-forecasts-2017-2022 .
Some points from TOC:
1. INTRODUCTION
1.1 Report Description
1.2 Research Methodology
1.3 Stakeholders
1.1 Report Description
1.2 Research Methodology
1.3 Stakeholders
2. EXECUTIVE SUMMARY
2.1 Key Findings
2.2 Market Overview
2.1 Key Findings
2.2 Market Overview
Purchase a copy of Opthalmic Drugs Market visit @ http://www.orbisresearch.com/contact/purchase/219589
For more information contact sales@orbisresearch.com .
3. MARKET OVERVIEW
3.1 Market Defenition
3.1.1 Introduction
3.2 Market Segmentation
3.2.1 Opthalmic Diseases
3.2.2 Opthalmic Drugs
3.2.3 Opthalmic Devices
3.3 Market Drivers
3.3.1 Demographic shift and impact of prevalence of eye disease
3.3.2 Availability of new drugs and devices
3.3.3 Growth in Cataract Volume
3.4 Market Constraints
3.4.1 Increasing Healthcare costs
3.4.2 Economic Slowdown in developed markets
3.1 Market Defenition
3.1.1 Introduction
3.2 Market Segmentation
3.2.1 Opthalmic Diseases
3.2.2 Opthalmic Drugs
3.2.3 Opthalmic Devices
3.3 Market Drivers
3.3.1 Demographic shift and impact of prevalence of eye disease
3.3.2 Availability of new drugs and devices
3.3.3 Growth in Cataract Volume
3.4 Market Constraints
3.4.1 Increasing Healthcare costs
3.4.2 Economic Slowdown in developed markets
4. GLOBAL MARKETS: SEGEMENTATION BY TYPE OF DRUGS
4.1 Anti Glaucoma Drugs
4.2 Opthalmic Infection Drugs
4.3 Opthalmic Inflammation Durgs
4.4 Opthalmic Lubricants
4.5 Mydriasis Drugs
4.6 Opthalmic Swelling
4.1 Anti Glaucoma Drugs
4.2 Opthalmic Infection Drugs
4.3 Opthalmic Inflammation Durgs
4.4 Opthalmic Lubricants
4.5 Mydriasis Drugs
4.6 Opthalmic Swelling
5. GLOBAL MARKETS: SEGMENTATION BY GEOGRAPHY
5.1 North America
5.1.1 US
5.1.2 Canada
5.2 Europe
5.2.1 UK
5.2.2 Germany
5.2.3 France
5.3 APAC
5.3.1 India
5.3.2 China
5.3.3 South Korea
5.3.4 Japan
5.4 Rest of the World
5.4.1 Brazil
5.4.2 Middle East
5.4.3 Australia
5.1 North America
5.1.1 US
5.1.2 Canada
5.2 Europe
5.2.1 UK
5.2.2 Germany
5.2.3 France
5.3 APAC
5.3.1 India
5.3.2 China
5.3.3 South Korea
5.3.4 Japan
5.4 Rest of the World
5.4.1 Brazil
5.4.2 Middle East
5.4.3 Australia
About Us:
Orbis Research (orbisresearch.com) is a
single point aid for all your market research requirements. We have vast
database of reports from the leading publishers and authors across the globe.
We specialize in delivering customized reports as per the requirements of our
clients. We have complete information about our publishers and hence are sure
about the accuracy of the industries and verticals of their specialization.
This helps our clients to map their needs and we produce the perfect required
market research study for our clients.
Contact Information:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Follow Us on LinkedIn: https://www.linkedin.com/company/orbis-research
Follow us on Twitter:
https://twitter.com/orbisresearch
Like us on Facebook:
https://www.facebook.com/pages/Orbis-Research/820969017982115
No comments:
Post a Comment